The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
The influence of age on the development of the hepatitis B carrier state
Abstract
The relation between the age at infection with hepatitis B virus (HBV) and the development of the carrier state is examined by using data from a number of published and unpublished surveys. A remarkably consistent relation was found. Infants infected perinatally (within the first 6 months of life) were found to have a high probability of becoming carriers (0.885; 95% C.L. 0.84-0.93). Over the infant and early childhood age classes there was found to be a sharp decrease in the proportion of infections which lead to the carrier state. By adulthood (over 15 years) the probability of developing the carrier status was found to be about 0.1. A model was fitted to the data by using maximum likelihood, which provides a good empirical description of the observed data and can be used to predict the expected probability of developing the carrier state given the age at infection. It is postulated that, as a result of this rapid decline in the probability of becoming a carrier during early childhood, a mass childhood immunization campaign, which will tend to postpone the average age at infection in the unvaccinated community, will have a disproportionately large impact on the rate of generation of new carriers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Infectious Diseases of Humans: Dynamics and Control
Anderson, R. M., & May, R. M. (1991) · doi:10.1093/oso/9780198545996.001.0001 · Cited by 6,179
Hall, A. J. (1992) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(92)90276-i · Cited by 2,131
Vertical Transmission of Hepatitis B Antigen in Taiwan
Stevens, C. E., Beasley, R. P., Tsui, J., & Lee, W.-C. (1975) · New England Journal of Medicine · doi:10.1056/nejm197504102921503 · Cited by 1,022
McMahon, B. J., Alward, W. L. M., Hall, D. B., Heyward, W. L., Bender, T. R., Francis, D. P., & Maynard, J. E. (1985) · Journal of Infectious Diseases · doi:10.1093/infdis/151.4.599 · Cited by 832
Wong, V. W., Reesink, H., Ip, H. H., Nco Lelie, P., Reerink-Brongers, E., Yeung, C. Y., & Ma, H. K. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92388-2 · Cited by 480
Viral hepatitis. New light on an old disease
Krugman, S. (1970) · JAMA · doi:10.1001/jama.212.6.1019 · Cited by 348
Stevens, C. E., Neurath, R. A., Beasley, R. P., & Szmuness, W. (1979) · Journal of Medical Virology · doi:10.1002/jmv.1890030310 · Cited by 331
Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults
Tassopoulos, N. C., Papaevangelou, G. J., Sjogren, M. H., Roumeliotou-karayannis, A., Gerin, J. L., & Purcell, R. H. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)90614-7 · Cited by 271
Hadler, S. C., Judson, F. N., O'Malley, P. M., Altman, N. L., Penley, K., Buchbinder, S., Schable, C. A., Coleman, P. J., Ostrow, D. N., & Francis, D. R. (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/163.3.454 · Cited by 260
A Serologic Follow-up of the 1942 Epidemic of Post-Vaccination Hepatitis in the United States Army
Seeff, L. B., Beebe, G. W., Hoofnagle, J. H., Norman, J. E., Buskell-Bales, Z., Waggoner, J. G., Kaplowitz, N., Koff, R. S., Petrini, J. L., Schiff, E. R., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198704163161601 · Cited by 254
Cited by
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Schweitzer, A., Horn, J., Mikolajczyk, R. T., Krause, G., & Ott, J. J. (2015) · The Lancet · doi:10.1016/s0140-6736(15)61412-x · Cited by 2,742
Schillie, S., Vellozzi, C., Reingold, A., Harris, A., Haber, P., Ward, J. W., & Nelson, N. P. (2018) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6701a1 · Cited by 815
Sheena, B. S., Hiebert, L., Han, H., Ippolito, H., Abbasi-Kangevari, M., Abbasi-Kangevari, Z., Abbastabar, H., Abdoli, A., Abubaker Ali, H., Adane, M. M., et al. (2022) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(22)00124-8 · Cited by 805
(2005) · PsycEXTRA Dataset · doi:10.1037/e548682006-001 · Cited by 753
A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
Goldstein, S. T., Zhou, F., Hadler, S. C., Bell, B. P., Mast, E. E., & Margolis, H. S. (2005) · International Journal of Epidemiology · doi:10.1093/ije/dyi206 · Cited by 743
Infections as a major preventable cause of human cancer
Kuper, H., Adami, H. ‐., & Trichopoulos, D. (2000) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2000.00742.x · Cited by 740
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
Cooke, G. S., Andrieux-Meyer, I., Applegate, T. L., Atun, R., Burry, J. R., Cheinquer, H., Dusheiko, G., Feld, J. J., Gore, C., Griswold, M. G., et al. (2019) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(18)30270-x · Cited by 535
Sexually Transmitted Infections Among US Women and Men: Prevalence and Incidence Estimates, 2018
Kreisel, K. M., Spicknall, I. H., Gargano, J. W., Lewis, F. M. T., Lewis, R. M., Markowitz, L. E., Roberts, H., Johnson, A. S., Song, R., St. Cyr, S. B., et al. (2021) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000001355 · Cited by 530
Shouval, D. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00152-1 · Cited by 470
Epidemiology of Hepatitis B Virus Infection and Impact of Vaccination on Disease
Nelson, N. P., Easterbrook, P. J., & McMahon, B. J. (2016) · Clinics in Liver Disease · doi:10.1016/j.cld.2016.06.006 · Cited by 366
The Prevalence of Hepatitis B Virus Infection in the United States in the Era of Vaccination
Wasley, A., Kruszon‐Moran, D., Kuhnert, W., Simard, E. P., Finelli, L., McQuillan, G., & Bell, B. (2010) · The Journal of Infectious Diseases · doi:10.1086/653622 · Cited by 351
Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes
Kramvis, A., & Kew, M. C. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00098.x · Cited by 347
Hepatitis B Virus Epidemiology
MacLachlan, J. H., & Cowie, B. C. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a021410 · Cited by 339
ACG Clinical Guideline: Liver Disease and Pregnancy
Tran, T. T., Ahn, J., & Reau, N. S. (2016) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.430 · Cited by 304
Pattyn, J., Hendrickx, G., Vorsters, A., & Van Damme, P. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa668 · Cited by 282
Hepatitis B vaccination: The key towards elimination and eradication of hepatitis B
Chen, D.-S. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.01.002 · Cited by 261
Mechanisms linking pathogens-associated inflammation and cancer
Porta, C., Riboldi, E., & Sica, A. (2011) · Cancer Letters · doi:10.1016/j.canlet.2010.10.012 · Cited by 119
Vaccines to Prevent Infections by Oncoviruses
Schiller, J. T., & Lowy, D. R. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134019 · Cited by 101
Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world
Toor, J., Echeverria-Londono, S., Li, X., Abbas, K., Carter, E. D., Clapham, H. E., Clark, A., de Villiers, M. J., Eilertson, K., Ferrari, M., et al. (2021) · eLife · doi:10.7554/elife.67635 · Cited by 97
Cohn, J., Owiredu, M. N., Taylor, M. M., Easterbrook, P., Lesi, O., Francoise, B., Broyles, L. N., Mushavi, A., Van Holten, J., Ngugi, C., et al. (2021) · Bulletin of the World Health Organization · doi:10.2471/blt.20.272559 · Cited by 64
Metadata
- Venue
- Proceedings of the Royal Society of London. Series B: Biological Sciences
- Publisher
- The Royal Society
- Published
- 1993-08-23
- Volume
- 253
- Issue
- 1337
- Pages
- 197-201
- ISSN
- 0080-4649 (ISSN-L)
- 0962-8452
- 1471-2954
- OpenAlex
- W2014482581
- Cited by
- 424
- References
- 18
- FWCI
- 2.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.